scholarly journals Klatskin tumor presenting as unresectable perihilar hepatic mass: A case report

2021 ◽  
Vol 16 (9) ◽  
pp. 2537-2541
Author(s):  
Thierry Romeo Yehouenou Tessi ◽  
Behyamet Onka ◽  
Maniani Abdel ilah Drissi ◽  
Hounayda Jerguigue ◽  
Rachida Latib ◽  
...  
2017 ◽  
Vol 17 (2) ◽  
pp. 558-561 ◽  
Author(s):  
Juyoung Ryu ◽  
Kangwook Lee ◽  
Changmug Joe ◽  
JongCheon Joo ◽  
Namhun Lee ◽  
...  

Hyperthermia, which is a noninvasive treatment that causes tumor cells to become heated and that works in synergy with anticancer drugs and radiation therapy, is emerging as a promising treatment for patients with cancer. The purpose of this study is to report the efficacy of hyperthermia combined with chemotherapy (gemcitabine/cisplatin) for the treatment of a patient with unresectable cholangiocarcinoma. A 54-year-old man was diagnosed as hilar cholangiocarcinoma (Klatskin tumor) and was administered neoadjuvant and preoperative radiation with chemotherapy. However, because the treatment with radiation and chemotherapy was not successful, he decided to undergo hyperthermia combined with chemotherapy as a second treatment option. He was suffering from fatigue, dyspepsia, epigastralgia, and jaundice. Hyperthermia combined with chemotherapy was administered 32 times over a period of 4 months. The patient experienced no critical complications, and the patient’s condition improved, with the carbohydrate antigen 19-9 (CA 19-9) and the total bilirubin levels being relatively lowered. In addition, the computed tomography scan showed that the cholangiocarcinoma had not progressed. In conclusion, this case report suggests radiofrequency hyperthermia combined with chemotherapy may be a promising treatment option for patients with unresectable cholangiocarcinoma.


2019 ◽  
Vol 114 (1) ◽  
pp. S1365-S1366
Author(s):  
Natalie Z. Wong ◽  
Matthew J. Stotts ◽  
Irini Daskalaki ◽  
Evan S. Siegelman ◽  
Kenneth D. Rothstein

2015 ◽  
Vol 39 (1) ◽  
pp. 117-121 ◽  
Author(s):  
Marleen C. A. M. Melenhorst ◽  
Hester J. Scheffer ◽  
Laurien G. P. H. Vroomen ◽  
Geert Kazemier ◽  
M. Petrousjka van den Tol ◽  
...  

2021 ◽  
Vol 25 (3) ◽  
pp. 426-430
Author(s):  
Celeste Del Basso ◽  
Roberto Luca Meniconi ◽  
Sofia Usai ◽  
Nicola Guglielmo ◽  
Marco Colasanti ◽  
...  

2020 ◽  
Vol 77 ◽  
pp. 260-263
Author(s):  
Mersad Alimoradi ◽  
Etienne El-Helou ◽  
Hassan Sabra ◽  
Pierre Hani ◽  
Raja Wakim

2018 ◽  
Vol 3 (2) ◽  
pp. 157-163
Author(s):  
Anke Mittelstaedt ◽  
Peter N. Meier ◽  
Eva Dankoweit-Timpe ◽  
Beate Christ ◽  
Joachim Jaehne

AbstractBackground:Even though IgG4-related disease has gained increased attention worldwide, the diagnosis remains challenging. IgG4-related sclerosing cholangitis (IgG4-SC) is not well described in the western hemisphere and may mimic cholangiocarcinoma (CC), especially when occurring without other symptoms such as, e.g. concurrent pancreatitis or retroperitoneal fibrosis. We present a case to add further information to the diagnosis and treatment of this challenging disease.Case report:A 60-year-old male patient presented with painless jaundice. Prior medical history showed diabetes mellitus type I, high blood pressure, and deep vein thrombosis. Diagnostic investigations were strongly suspicious of a Klatskin tumor, although biopsies were inconclusive. The tumor marker Carbohydrate Antigen 19-9 (CA 19-9) was elevated. Prior to the recommended surgery, the patient had two second opinions in two different university hospitals, both arguing for surgery as well. The patient received hilar resection with right hemihepatectomy. During the postoperative course, some major complications occurred, i.e. recurrent pleural effusion, abscess in the liver resection area, sepsis, ileus, and restricted liver metabolism. Treatment with prednisolone did not show any improvement. Approximately 3 months after surgery, the patient died in consequence of acute respiratory failure. Histology showed no signs of CC, but IgG4-SC could be diagnosed.Conclusion:In the case of preoperative signs of CC, differential diagnosis of IgG4-SC needs to be considered, in particular, in cases with missing histologic proof of malignant disease.


2004 ◽  
Vol 30 (1) ◽  
pp. 90-92 ◽  
Author(s):  
H. S. Park ◽  
J. K. Han ◽  
H. S. Lee ◽  
K. H. Lee ◽  
S. H. Kim ◽  
...  

2014 ◽  
Vol 20 (2) ◽  
pp. 60
Author(s):  
Nnabuike Chibuoke Ngene ◽  
Emeka F Orie ◽  
Thinagrin D Naidoo ◽  
Jagidesa Moodley

Sign in / Sign up

Export Citation Format

Share Document